Proteasome inhibitors have gained significant attention due to their potential in treating various diseases, particularly cancers. The proteasome plays a critical role in regulating the cell cycle, apoptosis, and other cellular processes. By inhibiting the proteasome, these drugs can induce apoptosis in cancer cells, which are more dependent on the proteasome for survival compared to normal cells. This makes proteasome inhibitors a valuable tool in oncology.
